There's something deeply backwards about the current conversation in American medicine, and a recent wave of hospital rankings has made it impossible to ignore. We're spending enormous energy measuring and rewarding how *pleasant* the healthcare experience feels while largely overlooking who gets access to that experience in the first place.
The latest hospital rankings celebrate institutions for patient satisfaction scores: cleaner rooms, friendlier staff, shorter wait times in comfortable lobbies. These metrics matter, certainly. But they've become the dominant signal of hospital quality precisely because they're easy to measure and market. Meanwhile, the harder questions about equity, drug availability, and who benefits from medical innovation quietly fade into background noise.
Consider what's happening at the intersection of these concurrent trends. Major pharmaceutical companies are consolidating vaccine developers and launching drugs into markets with profound distribution challenges. Simultaneously, we're recalling millions of insulin pumps due to safety defects. Yet the hospitals earning accolades for "patient experience" tend to be the same institutions where patients with robust insurance navigate seamless digital check-ins and get their medications reliably.
The uncomfortable truth: excellent patient experience often correlates with patient wealth.
This isn't entirely the hospitals' fault. They operate within a system that incentivizes visible, measurable satisfaction over harder-to-quantify outcomes like equitable access or whether a diabetic patient in an underserved area can actually obtain a functioning insulin pump. It's easier to improve a lobby than to solve supply chain problems that affect medication availability across different regions.
The industry's reward structure has created perverse incentives. Healthcare systems invest in amenities and customer service experiences because those directly impact their rankings, their reputations, and their ability to attract insured patients. This makes business sense. But it also means resources flow toward making the insured experience better while systemic access problems receive comparatively less institutional priority.
We should ask ourselves: what should we actually be celebrating in medicine?
A hospital that achieves perfect patient satisfaction scores while operating in a wealthy zip code tells us something different than one achieving similar scores while serving a diverse, lower-income population. A pharmaceutical company acquiring vaccine developers while addressing actual vaccine gaps in developing regions sends a different message than one pursuing similar acquisitions primarily for market consolidation.
The recent headlines hint at these contradictions. Powerful medications exist but don't reach people who need them. Equipment fails at scale, affecting vulnerable patients. Meanwhile, the conversation at major industry conferences centers on which hospitals made the "best of" lists.
This matters because incentive structures shape behavior across entire industries. When hospital networks know they'll be ranked on patient experience scores, they'll optimize for those metrics. When pharmaceutical companies understand that acquisitions and market positioning matter more than distribution equity, they'll prioritize accordingly. The system isn't broken; it's working exactly as designed. It's just designed to reward the wrong things.
I'm not arguing patient experience shouldn't matter. Dignity and comfort in healthcare are genuine goods. But they shouldn't eclipse our collective concern for access and equity.
The question facing the medical industry is whether it wants to celebrate an increasingly excellent experience for an increasingly narrow group, or whether it's willing to tackle the messier work of ensuring good care reaches further. Right now, the incentives push toward the former.
Until we reward healthcare systems and companies for solving access problems with the same enthusiasm we show for hospitality improvements, we'll keep applauding a system that works wonderfully for some while leaving others behind.